Tumor Neoangiogenesis and Flow Congestion: A Parallel to the Braess Paradox?

Circ Res. 2016 Sep 2;119(6):711-3. doi: 10.1161/CIRCRESAHA.116.309411.

Authors

Stefan Kippenberger¹, Markus Meissner², Roland Kaufmann², Igor Hrgovic², Nadja Zöller², Johannes Kleemann²

Affiliations

¹ From the Department of Dermatology, Allergy and Venereology, University of Frankfurt Medical School, Frankfurt/Main, Germany. kippenberger@em.uni-frankfurt.de.
² From the Department of Dermatology, Allergy and Venereology, University of Frankfurt Medical School, Frankfurt/Main, Germany.

PMID: 27587409
DOI: 10.1161/CIRCRESAHA.116.309411

No abstract available

Keywords: angiostatins; bevacizumab; hypoxia-inducible factor 1, α-subunit; neoplasms; vascular endothelial growth factor A.

Publication types

Review

MeSH terms

Angiogenesis Inhibitors / pharmacology
Angiogenesis Inhibitors / therapeutic use*
Animals
Humans
Neoplasms / drug therapy*
Neoplasms / physiopathology*
Neovascularization, Pathologic / drug therapy*
Neovascularization, Pathologic / physiopathology*
Tumor Microenvironment / drug effects
Tumor Microenvironment / physiology*

Substances

Angiogenesis Inhibitors